RACHEL CAMPBELL: Open Payments
NPI 1972884658 · CHARLESTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,778 in 102 payments from 20 companies in 2025. Trend: 2023 $791 · 2024 $960 · 2025 $1,778
Food & beverage: $1,778
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 29 | $513 |
| Novartis Pharmaceuticals Corporation | 15 | $271 |
| AstraZeneca Pharmaceuticals LP | 9 | $211 |
| Amgen Inc. | 15 | $184 |
| Astellas Pharma US Inc | 3 | $75 |
| PFIZER INC. | 4 | $72 |
| ABBVIE INC. | 4 | $69 |
| Sumitomo Pharma America, Inc. | 3 | $56 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $47 |
| Exact Sciences Corporation | 3 | $44 |
Products named: LEQVIO, Ozempic, Rybelsus, FASENRA, AIRSUPRA, Wegovy, Veozah, OTEZLA.
Industry payments across WV — which companies pay providers there.
